Ross procedure provides survival benefit over mechanical valve in adults: a propensity-matched nationwide analysis.
Jan GofusPetr FilaSvetlana DrabkovaPavel ZacekJiri OndrasekPetr NěmecJan SterbaMartin TunaJiri JarkovskyJan VojacekPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2022)
The Ross procedure offers a significant midterm survival benefit over mAVR. The procedures have a comparable risk of perioperative complications. Patients after mAVR have reduced survival. Thus, the Ross procedure should be the preferred treatment option for young and middle-aged adults with aortic valve disease in dedicated centres.
Keyphrases
- aortic valve
- middle aged
- aortic stenosis
- transcatheter aortic valve replacement
- ejection fraction
- aortic valve replacement
- transcatheter aortic valve implantation
- end stage renal disease
- minimally invasive
- free survival
- newly diagnosed
- chronic kidney disease
- prognostic factors
- cardiac surgery
- patients undergoing
- cross sectional
- risk factors
- coronary artery disease
- left ventricular
- atrial fibrillation